Joshua Aviram

7PUBLICATIONS
5CO-AUTHORS
Biologically active moleculesMolecular medicineTe mātauranga reo Māori (Māori language education)Characterisation of biological macromoleculesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 15, 2025
Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting.

Joshua Aviram

|Oct 28, 2023
Evaluating Sex Differences in Efficacy, Safety and Pharmacokinetics in Patients Treated with Cannabis by a Metered-Dose Inhaler.

Joshua Aviram, Marek Glezerman, Eytan Hayam

|Nov 16, 2022
Reply to Montmeat et al.

Joshua Aviram, Shiri Procaccia, Yelena Vysotski

|Oct 24, 2022
THC degradation does not impair the accuracy of THC doses aerosolized by the metered-dose SyqeAir inhaler: a 24-month stability trial.

Joshua Aviram, Daniella Atzmony, Anna Frenklakh

|May 27, 2022
Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler.

Joshua Aviram, Daniella Atzmony, Elon Eisenberg

|Sep 20, 2021
Sex differences in medical cannabis-related adverse effects.

Joshua Aviram, Gil M Lewitus, Yelena Vysotski

Pageof 2

Frequent Collaborators

2 joint publications

Gil M Lewitus

2 joint publications

David Meiri

1 joint publications

Idan Cohen

1 joint publications

Paula Berman